FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Harald Funke

Research Profile

Concepts & Ideas

Physiology

Chemicals & Drugs

Disorders

Genes & Molecular Sequences

Living Beings

Heterozygote

Procedures

Co-author Network

Publications

TOP 3
Gregor Kuhlenbaeumer; Andreas Huge; Klaus Berger; Christof Kessler; Henry Voelzke; Harald Funke; Florian Stoegbauer; Monika Stoll; E Bernd Ringelstein
Genetic variants in the C-reactive protein gene are associated with microangiopathic ischemic stroke.
Bernhard T Baune; Gerald Ponath; Matthias Rothermundt; Olaf Riess; Harald Funke; Klaus Berger
Association between genetic variants of IL-1beta, IL-6 and TNF-alpha cytokines and cognitive performance in the elderly general population of the MEMO-study.
Sandro Muntoni; Heiko Wiebusch; Marianne Jansen-Rust; Stephan Rust; Udo Seedorf; Helmut Schulte; Klaus Berger; Harald Funke; Gerd Assmann
Prevalence of cholesteryl ester storage disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Harald Funke (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Gregor Kuhlenbaeumer; Andreas Huge; Klaus Berger; Christof Kessler; Henry Voelzke; Harald Funke; Florian Stoegbauer; Monika Stoll; E Bernd Ringelstein
Genetic variants in the C-reactive protein gene are associated with microangiopathic ischemic stroke.
Cerebrovascular diseases (Basel, Switzerland) 2010;30(5):476-82.
2008: Bernhard T Baune; Gerald Ponath; Matthias Rothermundt; Olaf Riess; Harald Funke; Klaus Berger
Association between genetic variants of IL-1beta, IL-6 and TNF-alpha cytokines and cognitive performance in the elderly general population of the MEMO-study.
Psychoneuroendocrinology 2008;33(1):68-76.
2007: Sandro Muntoni; Heiko Wiebusch; Marianne Jansen-Rust; Stephan Rust; Udo Seedorf; Helmut Schulte; Klaus Berger; Harald Funke; Gerd Assmann
Prevalence of cholesteryl ester storage disease.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(8):1866-8.
2007: Klaus Berger; Florian Stögbauer; Monika Stoll; Jürgen Wellmann; Andreas Huge; Suzanne Cheng; Christof Kessler; Ulrich John; Gerd Assmann; E Bernd Ringelstein; Harald Funke
The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case-control studies.
Human genetics 2007;121(2):169-78.
2006: Gregor Kuhlenbäumer; K Berger; A Huge; E Lange; Christof Kessler; U John; Harald Funke; Darius Günther Nabavi; Florian Stögbauer; E Bernd Ringelstein; M Stoll
Evaluation of single nucleotide polymorphisms in the phosphodiesterase 4D gene (PDE4D) and their association with ischaemic stroke in a large German cohort.
Journal of neurology, neurosurgery, and psychiatry 2006;77(4):521-4.
2002: Dirk Isbrandt; Patrick Friederich; Anna Solth; Wilhelm Haverkamp; Andreas Ebneth; Martin Borggrefe; Harald Funke; Kathrin Sauter; Günter Breithardt; Olaf Pongs; Eric Schulze-Bahr
Identification and functional characterization of a novel KCNE2 (MiRP1) mutation that alters HERG channel kinetics.
Journal of molecular medicine (Berlin, Germany) 2002;80(8):524-32.
2002: Gerold Mönnig; Eric Schulze-Bahr; Horst Wedekind; Lars Eckardt; Paulus Kirchhof; Harald Funke; S Kotthoff; J Vogt; G Assmann; G Breithardt; W Haverkamp
[Clinical aspects and molecular genetics of the Jervell- and Lange-Nielsen Syndrome].
Zeitschrift für Kardiologie 2002;91(5):380-8.
2001: Horst Wedekind; Jeroen P P Smits; Eric Schulze-Bahr; R Arnold; Marieke W Veldkamp; Thomas Bajanowski; Martin Borggrefe; Bernd Brinkmann; I Warnecke; Harald Funke; Zahurul A Bhuiyan; Arthur A M Wilde; Günter Breithardt; Wilhelm Haverkamp
De novo mutation in the SCN5A gene associated with early onset of sudden infant death.
Circulation 2001;104(10):1158-64.
2001: Eric Schulze-Bahr; M Schwarz; S Hauenschild; Horst Wedekind; Harald Funke; Wilhelm Haverkamp; Günter Breithardt; Olaf Pongs; Dirk Isbrandt; S Hoffman
A novel long-QT 5 gene mutation in the C-terminus (V109I) is associated with a mild phenotype.
Journal of molecular medicine (Berlin, Germany) 2001;79(9):504-9.
2001: Peter Young; K Grote; Gregor Kuhlenbäumer; O Debus; H Kurlemann; Hartmut Halfter; Harald Funke; E Bernd Ringelstein; Florian Stögbauer
Mutation analysis in Chariot-Marie Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity.
Journal of neurology 2001;248(5):410-5.
2001: G Moennig; Eric Schulze-Bahr; Horst Wedekind; Martin Borggrefe; Harald Funke; M Toelle; Paulus Kirchhof; Lars Eckardt; Gerd Assmann; Günter Breithardt; Wilhelm Haverkamp
Clinical value of electrocardiographic parameters in genotyped individuals with familial long QT syndrome.
Pacing and clinical electrophysiology : PACE 2001;24(4 Pt 1):406-15.
2000: Peter Young; F Stögbauer; B Eller; Peter De Jonghe; Ann Löfgren; Vincent Timmerman; Bernd Rautenstrauss; K Oexle; H Grehl; Gregor Kuhlenbäumer; Christine Van Broeckhoven; E B Ringelstein; Harald Funke
PMP22 Thr118Met is not a clinically relevant CMT1 marker.
Journal of neurology 2000;247(9):696-700.
2000: G Moennig; Heiko Wiebusch; A Enbergs; Anja Dorszewski; Sebastian Kerber; Helmut Schulte; C Vielhauer; W Haverkamp; Gerd Assmann; Günter Breithardt; Harald Funke
Detection of missense mutations in the genes for lipoprotein lipase and hepatic triglyceride lipase in patients with dyslipidemia undergoing coronary angiography.
Atherosclerosis 2000;149(2):395-401.
2000: Eric Schulze-Bahr; Wilhelm Haverkamp; Martin Borggrefe; Horst Wedekind; Gerold Mönnig; J Mergenthaler; Gerd Assmann; Harald Funke; Günter Breithardt
Molecular genetics of arrhythmias--a new paradigm.
Zeitschrift für Kardiologie 2000;89 Suppl 4():IV12-22.
1999: Wilhelm Haverkamp; Eric Schulze-Bahr; Gerold Mönnig; Horst Wedekind; Martin Borggrefe; Harald Funke; Günter Breithardt
[Congenital and "acquired QT syndromes].
Herz 1999;24(7):587-90.
1999: Alan T Remaley; Stephan Rust; Marie Rosier; Catherine L Knapper; L Naudin; cyril broccardo; K M Peterson; Christian A Koch; Isabelle Arnould; C Prades; Nicolas Duverger; Harald Funke; G Assman; M Dinger; Michael Dean; Giovanna Chimini; Silvia Santamarina-Fojo; Donald S Fredrickson; Patrice DENEFLE; H Bryan Brewer
Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(22):12685-90.
1999: Wilhelm Haverkamp; Gerold Mönnig; Horst Wedekind; Eric Schulze-Bahr; Martin Borggrefe; Gerd Assmann; Harald Funke; Günter Breithardt
[Clinical aspects and molecular genetics of the long QT-syndrome].
Deutsche medizinische Wochenschrift (1946) 1999;124(33):972-9.
1999: Stephan Rust; Marie Rosier; Harald Funke; J Real; Z Amoura; J C Piette; Jean-François Deleuze; H Bryan Brewer; Nicolas Duverger; Patrice DENEFLE; Gerd Assmann
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1.
Nature genetics 1999;22(4):352-5.
1999: Harald Funke; G Assmann
Strategies for the assessment of genetic coronary artery disease risk.
Current opinion in lipidology 1999;10(3):285-91.
1999: Eric Schulze-Bahr; Horst Wedekind; Wilhelm Haverkamp; Martin Borggrefe; Gerd Assmann; Günter Breithardt; Harald Funke
The LQT syndromes--current status of molecular mechanisms.
Zeitschrift für Kardiologie 1999;88(4):245-54.
1998: Stephan Rust; M Walter; Harald Funke; Arnold von Eckardstein; Paul Cullen; H Y Kroes; R Hordijk; J Geisel; JJ Kastelein; H O Molhuizen; M Schreiner; A Mischke; H W Hahmann; Gerd Assmann
Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy.
Nature genetics 1998;20(1):96-8.
1998: Florian Stögbauer; Peter Young; M Kerschensteiner; E Bernd Ringelstein; Gerd Assmann; Harald Funke
Recurrent brachial plexus palsies as the only clinical expression of hereditary neuropathy with liability to pressure palsies associated with a de novo deletion of the peripheral myelin protein-22 gene.
Muscle & nerve 1998;21(9):1199-201.
1998: Peter Young; Florian Stögbauer; Heiko Wiebusch; Ann Löfgren; Vincent Timmerman; Christine Van Broeckhoven; E Bernd Ringelstein; Gerd Assmann; Harald Funke
PCR-based strategy for the diagnosis of hereditary neuropathy with liability to pressure palsies and Charcot-Marie-Tooth disease type 1A.
Neurology 1998;50(3):760-3.
1998: Florian Stögbauer; Peter Young; Heiko Wiebusch; Vincent Timmerman; Gregor Kuhlenbäumer; Eva Nelis; E Bernd Ringelstein; Gerhard Kurlemann; Gerd Assmann; Christine Van Broeckhoven; Harald Funke
Absence of mutations in peripheral myelin protein-22, myelin protein zero, and connexin 32 in autosomal recessive Dejerine-Sottas syndrome.
Neuroscience letters 1998;240(1):1-4.
1997: Eric Schulze-Bahr; Q Wang; Horst Wedekind; Wilhelm Haverkamp; Q Chen; Y Sun; C Rubie; M Hördt; J A Towbin; Martin Borggrefe; Gerd Assmann; X Qu; J C Somberg; Günter Breithardt; C Oberti; Harald Funke
KCNE1 mutations cause jervell and Lange-Nielsen syndrome.
Nature genetics 1997;17(3):267-8.
1997: Eric Schulze-Bahr; Wilhelm Haverkamp; Horst Wedekind; C Rubie; M Hördt; Martin Borggrefe; Gerd Assmann; Günter Breithardt; Harald Funke
Autosomal recessive long-QT syndrome (Jervell Lange-Nielsen syndrome) is genetically heterogeneous.
Human genetics 1997;100(5-6):573-6.
1997: Harald Funke
Genetic determinants of high density lipoprotein levels.
Current opinion in lipidology 1997;8(3):189-96.
1997: Heiko Wiebusch; Harald Funke; K Saku; K Arakawa; Gerd Assmann
Mutational analysis of two frequently observed lipoprotein lipase gene variants in the Japanese population.
Journal of inherited metabolic disease 1997;20(1):108-9.
1997: Petteri Knudsen; Marjatta Antikainen; Mikko Uusi-Oukari; Sonja Jaari; Sanni Lahdenperä; A Bensadoun; Harald Funke; Heiko Wiebusch; Gerd Assmann; Marja-Riitta Taskinen; Christian Ehnholm
Heterozygous hepatic lipase deficiency, due to two missense mutations R186H and L334F, in the HL gene.
Atherosclerosis 1997;128(2):165-74.
1997: Peter Young; Heiko Wiebusch; Florian Stögbauer; Bernd Ringelstein; Gerd Assmann; Harald Funke
A novel frameshift mutation in PMP22 accounts for hereditary neuropathy with liability to pressure palsies.
Neurology 1997;48(2):450-2.
1997: H Bucher; S Rampini; R W James; D Pometta; Harald Funke; Heiko Wiebusch; Gerd Assmann
Marked changes of lipid levels during puberty in a patient with lipoprotein lipase deficiency.
European journal of pediatrics 1997;156(2):121-5.
1997: Eric Bruckert; A von Eckardstein; Harald Funke; Isabel Beucler; Heiko Wiebusch; Gérard Turpin; Gerd Assmann
The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-IMilano.
Atherosclerosis 1997;128(1):121-8.
1996: S M Bijvoet; Heiko Wiebusch; Y Ma; PW Reymer; T Bruin; Henk D Bakker; Harald Funke; G Assmann; Michael R Hayden; John J P Kastelein
Compound heterozygosity for a known and a novel defect in the lipoprotein lipase gene (Asp250-->Asn; Ser251-->Cys) resulting in lipoprotein lipase (LPL) deficiency.
The Netherlands journal of medicine 1996;49(5):189-95.
1996: Eric Schulze-Bahr; Wilhelm Haverkamp; Günter Breithardt; Harald Funke; Heiko Wiebusch; Gerd Assmann
ECG repolarization patterns in chromosome 7-linked QT syndrome (LQTS 2)
Circulation 1996;94(9):2318-9.
1996: Roberto Miccoli; A Bertolotto; Renzo Navalesi; L Odoguardi; A Boni; J Wessling; Harald Funke; Heiko Wiebusch; A Eckardstein; G Assmann
Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease.
Circulation 1996;94(7):1622-8.
1996: Heiko Wiebusch; S Muntoni; Harald Funke; F Lu; Udo Seedorf; S Oberle; U Schwarzer; Gerd Assmann
A novel missense mutation (Gly2Arg) in the human lysosomal acid lipase gene is found in individuals with and without cholesterol ester storage disease (CESD).
Clinical genetics 1996;50(2):106-7.
1996: Jan Albert Kuivenhoven; H Weibusch; P Haydn Pritchard; Harald Funke; Rob Benne; G Assmann; John J P Kastelein
An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease).
The Journal of clinical investigation 1996;98(2):358-64.
1996: Peter Young; Heiko Wiebusch; Florian Stögbauer; Bernd Ringelstein; Gerd Assmann; Harald Funke
Four frequently observed polymorphisms in the 3'-UTR of human peripheral myelin protein 22 (PMP22): identification of different haplotypes.
Clinical genetics 1996;49(6):321-2.
1996: S Muntoni; Heiko Wiebusch; Harald Funke; Udo Seedorf; M Roskos; Helmut Schulte; K Saku; K Arakawa; A Balestrieri; Gerd Assmann
A missense mutation (Thr-6Pro) in the lysosomal acid lipase (LAL) gene is present with a high frequency in three different ethnic populations: impact on serum lipoprotein concentrations.
Human genetics 1996;97(2):265-7.
1996: Heiko Wiebusch; Harald Funke; R Santer; W Richter; Gerd Assmann
A novel missense (E163G) mutation in the catalytic subunit of lipoprotein lipase causes familial chylomicronemia.
Human mutation 1996;8(4):392.
1996: Heiko Wiebusch; Harald Funke; T Bruin; H Bucher; Arnold von Eckardstein; John J P Kastelein; Gerd Assmann
Compound heterozygosity for a known (D250N) and a novel (E410K) missense mutation in the C-terminal domain of lipoprotein lipase causes familial chylomicronemia.
Human mutation 1996;8(4):381-3.
1996: James S Owen; Heiko Wiebusch; Paul Cullen; G F Watts; V L M Lima; Harald Funke; Gerd Assmann
Complete deficiency of plasma lecithin-cholesterol acyltransferase (LCAT) activity due to a novel homozygous mutation (Gly-30-Ser) in the LCAT gene.
Human mutation 1996;8(1):79-82.
1995: Eric Schulze-Bahr; Wilhelm Haverkamp; Harald Funke
The long-QT syndrome.
The New England journal of medicine 1995;333(26):1783-4.
1995: Jan Albert Kuivenhoven; E J van Voorst tot Voorst; H Wiebusch; S M Marcovina; Harald Funke; G Assmann; P Haydn Pritchard; John J P Kastelein
A unique genetic and biochemical presentation of fish-eye disease.
The Journal of clinical investigation 1995;96(6):2783-91.
1995: Eric Schulze-Bahr; Wilhelm Haverkamp; Heiko Wiebusch; Helmut Schulte; M Hördt; Martin Borggrefe; Günter Breithardt; Gerd Assmann; Harald Funke
Molecular analysis at the Harvey Ras-1 gene in patients with long QT syndrome.
Journal of molecular medicine (Berlin, Germany) 1995;73(11):565-9.
1995: Renzo Navalesi; Roberto Miccoli; L Odoguardi; Harald Funke; Arnold von Eckardstein; Heiko Wiebusch; G Assmann
Genetically determined absence of HDL-cholesterol and coronary atherosclerosis.
Lancet 1995;346(8976):708-9.
1995: Jerzy-Roch Nofer; Arnold von Eckardstein; Heiko Wiebusch; W Weng; Harald Funke; Helmut Schulte; E Köhler; Gerd Assmann
Screening for naturally occurring apolipoprotein A-I variants: apo A-I(delta K107) is associated with low HDL-cholesterol levels in men but not in women.
Human genetics 1995;96(2):177-82.
1995: Heiko Wiebusch; Jerzy-Roch Nofer; Arnold von Eckardstein; Harald Funke; U Wahrburg; H Martin; E Köhler; Gerd Assmann
Electrophoretic screening for human apolipoprotein C-II variants: repeated identification of apolipoprotein C-II(K19T).
Journal of molecular medicine (Berlin, Germany) 1995;73(7):373-8.
1995: Udo Seedorf; Heiko Wiebusch; S Muntoni; N C Christensen; F Skovby; V Nickel; M Roskos; Harald Funke; L Ose; Gerd Assmann
A novel variant of lysosomal acid lipase (Leu336-->Pro) associated with acid lipase deficiency and cholesterol ester storage disease.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(6):773-8.
1995: S Muntoni; Heiko Wiebusch; Harald Funke; E Ros; Udo Seedorf; Gerd Assmann
Homozygosity for a splice junction mutation in exon 8 of the gene encoding lysosomal acid lipase in a Spanish kindred with cholesterol ester storage disease (CESD).
Human genetics 1995;95(5):491-4.
1995: Arnold von Eckardstein; Y Huang; S Wu; Harald Funke; G Noseda; Gerd Assmann
Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(5):691-703.
1995: J Heinrich; Harald Funke; Stephan Rust; Helmut Schulte; R Schönfeld; Ekkehart Köhler; Gerd Assmann
Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients.
Thrombosis research 1995;77(3):209-15.
1995: Heiko Wiebusch; Paul Cullen; James S Owen; D Collins; P S Sharp; Harald Funke; Gerd Assmann
Deficiency of lecithin:cholesterol acyltransferase due to compound heterozygosity of two novel mutations (Gly33Arg and 30 bp ins) in the LCAT gene.
Human molecular genetics 1995;4(1):143-5.
1994: R Römling; Arnold von Eckardstein; Harald Funke; C Motti; G C Fragiacomo; G Noseda; Gerd Assmann
A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(12):1915-22.
1994: S Lüttmann; Arnold von Eckardstein; W Wei; Harald Funke; E Köhler; R W Mahley; Gerd Assmann
Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III(Asp45-->Asn), in a Turkish patient.
Journal of lipid research 1994;35(8):1431-40.
1994: Arnold von Eckardstein; Harald Funke; A Chirazi; C Chen-Haudenschild; Helmut Schulte; R Schönfeld; Ekkehart Köhler; S Schwarz; A Steinmetz; Gerd Assmann
Sex-specific effects of the glutamine/histidine polymorphism in apo A-IV on HDL metabolism.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(7):1114-20.
1994: Y Ma; M S Liu; D Chitayat; T Bruin; U Beisiegel; Pascale Benlian; Luc Foubert; Jean Luc de Gennes; Harald Funke; I Forsythe
Recurrent missense mutations at the first and second base of codon Arg243 in human lipoprotein lipase in patients of different ancestries.
Human mutation 1994;3(1):52-8.
1993: Michael R Hayden; John J P Kastelein; Harald Funke; J D Brunzell; Y Ma
Phenotypic variation of mutations in the human lipoprotein-lipase gene.
Biochemical Society transactions 1993;21(2):506-9.
1993: Gerd Assmann; Arnold von Eckardstein; Harald Funke
High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Insights from mutations.
Circulation 1993;87(4 Suppl):III28-34.
1993: Harald Funke; Arnold von Eckardstein; Peter Pritchard; A E Hornby; Heiko Wiebusch; C Motti; M R Hayden; C Dachet; B Jacotot; U Gerdes
Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease.
The Journal of clinical investigation 1993;91(2):677-83.
1993: Arnold von Eckardstein; J Heinrich; Harald Funke; Helmut Schulte; R Schönfeld; Ekkehart Köhler; A Steinmetz; Gerd Assmann
Glutamine/histidine polymorphism in apo A-IV affects plasma concentrations of lipoprotein(a) and fibrin split products in coronary heart disease patients.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(2):240-6.
1992: E Köhler; A Bentrup; Harald Funke; M Sandkamp; H Schulte; Gerd Assmann
[Relationship between lipid metabolism disorders and age of first manifestations of coronary heart disease].
Zeitschrift für Kardiologie 1992;81(7):354-60.
1992: Arnold von Eckardstein; Harald Funke; M Schulte; Michael Erren; Helmut Schulte; Gerd Assmann
Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population.
American journal of human genetics 1992;50(5):1115-28.
1991: C Motti; Harald Funke; Stephan Rust; Alexander Dergunov; Gerd Assmann
Using mutagenic polymerase chain reaction primers to detect carriers of familial defective apolipoprotein B-100.
Clinical chemistry 1991;37(10 Pt 1):1762-6.
1991: Harald Funke; Arnold von Eckardstein; Peter Pritchard; J J Albers; John J P Kastelein; C Droste; Gerd Assmann
A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(11):4855-9.
1991: Arnold von Eckardstein; H Holz; M Sandkamp; W Weng; Harald Funke; Gerd Assmann
Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.
The Journal of clinical investigation 1991;87(5):1724-31.
1991: Harald Funke; Arnold von Eckardstein; Peter Pritchard; Michael Karas; J J Albers; Gerd Assmann
A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities.
The Journal of clinical investigation 1991;87(1):371-6.
1990: Arnold von Eckardstein; Harald Funke; M Walter; Klaus Altland; A Benninghoven; Gerd Assmann
Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure.
The Journal of biological chemistry 1990;265(15):8610-7.
1990: M Sandkamp; Harald Funke; Helmut Schulte; Ekkehart Köhler; Gerd Assmann
Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age.
Clinical chemistry 1990;36(1):20-3.
1989: Arnold von Eckardstein; Harald Funke; A Henke; Klaus Altland; A Benninghoven; Gerd Assmann
Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.
The Journal of clinical investigation 1989;84(6):1722-30.
1989: Gerd Assmann; Harald Funke; Gerd Schmitz
Low density lipoproteins and hypercholesterolemia.
Arzneimittel-Forschung 1989;39(8A):996-1003; discussion 1003-4.
1987: Harald Funke; J Klug; Gerd Assmann
Hind III RFLP in the lipoprotein lipase gene, (LPL).
Nucleic acids research 1987;15(21):9102.